HIGHLIGHTS
- who: . et al. from the The University of Queensland, Australia have published the paper: An intravenous anesthetic drug-propofol, in uences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: A narrative literature review, in the Journal: (JOURNAL)
- what: Clinical studies have shown that propofol is closely associated with postoperative prognosis for tumor patients, with the most extensive studies focusing on breast cancer (Wang et_al, 2018). In this review, the chemical properties, pharmacokinetics, clinical application and limitations and studies in animal tumor models of propofol were summarized, as well as the effects on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.